A Study of the Combinant Application of PN and GH in the Therapy of Critical Care Patients

安友仲,刘方,周静,谢百福,唐铭,王仲照
DOI: https://doi.org/10.3760/cma.j.issn.1674-635x.2000.01.060
2000-01-01
Abstract:Objective To study the effect of combinant applications of PN and GH in the therapy of critical care patients. Methods We treated 16 cases of critical care patients with the combination of PN and. GH, of which there were MOF in 4, acute pancreatitis in 1, the others are postoperative patients, including panereatic cancer in 3, colon cancer in 4, ovaries cancer in 2, lymphoma in 1. Male: Female = 11: 3, the average age is 65.85 ± 12.4, the usage of the GH is 4.5~8u/day. Results (1)9 cases were cured and the other 7 cases died from severe irdection, MOF and respiratory failure. (2)in the cases whose renal function is normal, the BUN level significantly declined after the therapy. (BUN = 9. 4393 ± 2. 068mmol/l before the therapy versus BUN = 7. 0564 ± 1. 882mmol/l after the therapy, P < 0.01 ) (3)in the 2 cases whose renal function were abnormal(Cr > 115umol/l ), the BUN level before the therapy were 19.19 mmol/l and 28.02mmol/l, and 28.81mmol/l and 33.74mmol/L after the therapy. (4) The TP and ALB level after the therapy were not significantly diferent from before. (31.8 ± 5.08g/l before the therapy versus 32.47 ± 6.43g/l aftet the therapy. P > 0.05). Conclusions In case of normal renal function, the combinant application of PN and GH in the therapy of critical care patients could reduce the BUN level in plasma. The clinical significance and its mechanism are to be further studied.
What problem does this paper attempt to address?